Summary & Overview
HCPCS C1899: Lead for Pacemaker/Cardioverter-Defibrillator Combination (Implantable)
HCPCS Level II code C1899 denotes an implantable lead for a combined pacemaker and cardioverter-defibrillator system. This component is central to device-based management of bradyarrhythmias and life-threatening ventricular arrhythmias, supporting both pacing and defibrillation functions. Nationally, accurate coding of device components like C1899 affects device inventory accounting, procedural billing, and reimbursement for implantation and replacement procedures.
Key national payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for combination pacemaker/ICD leads, the typical sites of service where these devices are implanted, and the common payer landscape affecting coverage and claim submission. The publication summarizes billing and utilization benchmarks, highlights relevant policy considerations that influence claim adjudication, and explains typical coding relationships for device components.
This resource is intended for revenue cycle managers, cardiac electrophysiology program administrators, and billing professionals seeking a clear, national-level summary of C1899 for operational and coding reference.
Billing Code Overview
HCPCS Level II code C1899 represents a lead for a pacemaker/cardioverter-defibrillator combination (implantable). The code applies to an implanted cardiac lead component used with combination pacemaker and implantable cardioverter-defibrillator systems.
Service type: Implantable cardiac lead placement and supply for combined pacemaker/cardioverter-defibrillator systems.
Typical site of service: Hospital inpatient or outpatient surgical setting, and ambulatory surgical centers where implantable cardiac device procedures are performed.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with ischemic cardiomyopathy and a history of symptomatic bradycardia and episodes of ventricular tachycardia presents for implantation of a combined pacemaker and implantable cardioverter-defibrillator (ICD) system. The procedure involves placing transvenous leads that provide both pacing and defibrillation capabilities: one or more pacing/sensing leads and a defibrillation lead tunneled to a subcutaneous generator pocket. Typical workflow includes pre-procedure device and lead selection, informed consent, device interrogation and programming, venous access (usually left subclavian or axillary), fluoroscopic lead positioning in the right atrium, right ventricle and coronary sinus as indicated, intraoperative testing (sensing, pacing thresholds, and defibrillation testing when indicated), generator connection, pocket closure, sterile dressing, and post-procedure telemetry monitoring. Typical site of service is an inpatient or outpatient hospital operating room or cardiac catheterization laboratory. The typical patient requires preoperative cardiac evaluation, perioperative antibiotic prophylaxis, and post-implant chest radiography to confirm lead position and rule out pneumothorax.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work, technical effort, or time substantially exceeds usual for device implantation due to complexity (document rationale). |